Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma
Neuroblastoma is a pediatric cancer of the developing sympathetic nervous system. High-risk neuroblastoma patients typically undergo an initial remission in response to treatment, followed by recurrence of aggressive tumors that have become refractory to further treatment. The need for biomarkers th...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-03-01
|
| Series: | Cancer Informatics |
| Online Access: | https://doi.org/10.1177/1176935119832910 |